首页> 外国专利> Obesity predisposition evaluation method and kit, and anti-obesity drug and screening method thereof, non-human animal, adipose tissue, adipocyte, transgenic mouse preparation method, antigen, antibody

Obesity predisposition evaluation method and kit, and anti-obesity drug and screening method thereof, non-human animal, adipose tissue, adipocyte, transgenic mouse preparation method, antigen, antibody

机译:肥胖症易感性评估方法和试剂盒,抗肥胖药及其筛选方法,非人类动物,脂肪组织,脂肪细胞,转基因小鼠的制备方法,抗原,抗体

摘要

PROBLEM TO BE SOLVED: To provide a method and kit for evaluating whether or not predisposition to obesity is present, an anti-obesity drug having an action to prevent or treat obesity or a condition or disease caused by obesity, a screening method therefor, and a gene relating thereto To provide a deficient non-human animal, its adipose tissue or adipocyte. A method for evaluating whether obesity or a predisposition to cause a condition or disease caused by obesity, comprising using a sample containing a human gene of a subject, and a copy number polymorphism in intron 1 of SLC25A24 gene (CNV), or a step of detecting a genetic polymorphism in a linkage disequilibrium relationship therewith is provided. When CNV in intron 1 of the SLC25A24 gene is 0, it may be evaluated as having a predisposition for causing obesity or a condition or disease caused by obesity. [Selection] Figure 1
机译:要解决的问题:提供一种用于评估是否存在肥胖症倾向的方法和试剂盒,一种具有预防或治疗肥胖症或由肥胖症引起的病症或疾病的作用的抗肥胖药,其筛查方法以及一种与之有关的基因,以提供一种有缺陷的非人类动物,其脂肪组织或脂肪细胞。一种评估肥胖或易导致肥胖的病症或病因的方法,该方法包括使用包含受试者的人类基因和SLC25A24基因(CNV)内含子1的拷贝数多态性的样品,或提供了一种检测与之连锁不平衡关系中的遗传多态性的方法。当SLC25A24基因的内含子1中的CNV为0时,可以将其评估为具有引起肥胖症或由肥胖症引起的病症或疾病的易感性。 [选择]图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号